News
Me gene privacy question takes a turn in bankruptcy Why a big AI player wants a quarter-million bucks from 23andMe Why a big ...
The likelihood for avoidance of five clinically important outcomes in patients with COPD and type 2 inflammation was greater ...
The Health Sciences Authority (HSA) has approved Dupixent (dupilumab) for adults as an add-on maintenance treatment for uncontrolled chronic obstructive pulmonary disease (COPD) characterized by ...
AbbVie’s Skyrizi took home the top spot for most pharma brand ad impressions in April 2025, according to data released by ...
They want to sue on behalf of a class of people “who purchased a Burger King menu item based on false and misleading advertising concerning the size and/or the amount of ingredients contained in ...
This story speaks of the decisions that companies have made about advertising are not merely budgetary choices, but reflections of deeper economic sentiment. In Q1 2025, those choices are painting a ...
The banning of pharmaceutical advertisements is not an assault on free speech. Big Pharma cannot be trusted with the health of Americans.
Enjoying a burger exactly the way you want to can be a bit of a ritual. KFC is tapping into ...
Dupixent (dupilumab) Interleukin-4 receptor alpha antagonist Treatment of patients aged 12 years and older with chronic spontaneous urticaria who remain symptomatic despite H1 antihistamine treatment.
The campaign can span multiple digital channels including display advertising, email, sponsored content, PPC, paid social and more. The campaign should drive efficiency in terms of ROI including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results